BioDatomics vs Neocor Technologies: Revenue, Funding & Team Size Compared
BioDatomics generates $567K in revenue; Neocor Technologies generates $583.4K. Neocor Technologies and BioDatomics are close to the same size by revenue. The table below compares BioDatomics and Neocor Technologies on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  BioDatomicsThis company |  Neocor Technologies |
|---|---|---|
| Revenue | $567K | $583.4K |
| Team size | 11 | 3 |
| Founded | 2010 | 2020 |
| HQ | Bethesda, United States | United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
BioDatomics at a glance
BioDatomics generates $567K in revenue with 11 employees, headquartered in Bethesda, United States.
- Revenue
- $567K
- Team size
- 11
- Founded
- 2010
BioDatomics provides tools for high throughput bioinformatics analysis optimized for next generation sequencing data analysis.
Neocor Technologies at a glance
Neocor Technologies generates $583.4K in revenue with 3 employees, headquartered in United States.
- Revenue
- $583.4K
- Team size
- 3
- Founded
- 2020
Neocor is a startup SaaS company in the B2B technology and software market. Neocor Fusion Ledger is a patent-pending application for Software Licensing and IT Asset Management.
Other BioDatomics alternatives
BioDatomics competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
BioDatomics vs Neocor Technologies: frequently asked questions
Is BioDatomics or Neocor Technologies bigger?
Neocor Technologies is the bigger company by revenue, at $583.4K against $567K for BioDatomics.
How much revenue does BioDatomics make?
BioDatomics generates $567K in annual revenue with a team of 11.
How much revenue does Neocor Technologies make?
Neocor Technologies generates $583.4K in annual revenue with a team of 3.